Clinical Trial Update: Efficacy and Safety of Upadacitinib in Inflammatory Bowel Disease

View source ↗

Summary

This clinical trial update notes recruitment status for evaluating the efficacy and safety of upadacitinib in inflammatory bowel disease, including Crohn's dise…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease
• Inflammatory Bowel Disease
• Ulcerative Colitis

Drugs mentioned

• Upadacitinib (Rinvoq) (upadacitinib)

Snippet

Sponsor: Xiang Gao | Conditions: Inflammatory Bowel Disease, Crohn's Disease | Status: RECRUITING